Praveen Praveen

Bundoora, VIC 3086, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Unveiling the Potential of Magainin Derivatives against Candida Species.

Unveiling the Potential of Magainin Derivatives against Candida Species.

Journal: Journal of medicinal chemistry

Published: April 25, 2026

Design and Synthesis of a Structurally Stabilized B‑Chain Antagonist Targeting Relaxin Family Peptide Receptor 3 (RXFP3).

Design and Synthesis of a Structurally Stabilized B‑Chain Antagonist Targeting Relaxin Family Peptide Receptor 3 (RXFP3).

Journal: ACS medicinal chemistry letters

Published: August 13, 2025

Aggregation-prone antimicrobial peptides target gram-negative bacterial nucleic acids and protein synthesis.

Aggregation-prone antimicrobial peptides target gram-negative bacterial nucleic acids and protein synthesis.

Journal: Acta biomaterialia

Published: October 05, 2024

Functionalized α-Cyanostilbene Derivatives for Detection of Hypoxia or Proteostasis Imbalance in Live Cells.

Functionalized α-Cyanostilbene Derivatives for Detection of Hypoxia or Proteostasis Imbalance in Live Cells.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: July 11, 2024

Total Chemical Synthesis of Aggregation-Prone Disulfide-Rich Starfish Peptides.

Total Chemical Synthesis of Aggregation-Prone Disulfide-Rich Starfish Peptides.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: March 06, 2024

Embracing the era of antimicrobial peptides with marine organisms.

Embracing the era of antimicrobial peptides with marine organisms.

Journal: Natural product reports

Published: September 25, 2023

Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.

Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.

Journal: International journal of molecular sciences

Published: July 10, 2023

Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.

Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.

Journal: ACS pharmacology & translational science

Published: March 13, 2023

A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.

A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.

Journal: International journal of molecular sciences

Published: March 10, 2023

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy.

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 21, 2022

A Novel Antimicrobial Hydrogel for the Management of Periodontal Diseases.

A Novel Antimicrobial Hydrogel for the Management of Periodontal Diseases.

Journal: International dental journal

Published: November 30, 2022

Engineering of a Biologically Active Insulin Dimer.

Engineering of a Biologically Active Insulin Dimer.

Journal: Journal of medicinal chemistry

Published: November 19, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026